Related Experiment Video
Updated: May 6, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Chronic kidney disease in acute coronary syndromes
Giancarlo Marenzi1, Angelo Cabiati, Emilio Assanelli
1Giancarlo Marenzi, Angelo Cabiati, Emilio Assanelli, Centro Cardiologico Monzino, IRCCS Department of Cardiovascular Sciences, University of Milan, 20138 Milan, Italy.
Insights
Patients with chronic kidney disease (CKD) face worse outcomes with acute coronary syndromes (ACS). This review examines evidence on managing these complex cases, focusing on therapies and revascularization strategies.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Coronary artery disease poses a significant burden in patients with chronic kidney disease (CKD).
- CKD is prevalent in acute coronary syndrome (ACS) patients, correlating with adverse short- and long-term prognoses.
- Managing ACS in CKD patients is challenging due to limited clinical trials and concerns about renal function and treatment toxicity.
Purpose of the Study:
- To review the epidemiology of CKD in ACS patients.
- To discuss the clinical and prognostic significance of CKD in ACS.
- To address uncertainties in medical therapies and revascularization strategies for ACS patients with CKD.
Main Methods:
- Literature review of existing evidence.
- Analysis of epidemiological data.
- Synthesis of clinical and prognostic information.
Main Results:
- CKD is common in ACS patients and linked to poorer outcomes.
- Patients with CKD are often excluded from clinical trials for ACS therapies.
- Proven medical therapies and revascularization strategies may be underutilized in this high-risk group.
Conclusions:
- CKD significantly impacts ACS patient outcomes.
- Further research is needed to optimize treatment strategies for ACS patients with CKD.
- Addressing therapeutic and revascularization uncertainties is crucial for improving care.
Abstract:
Chronic kidney disease (CKD) is associated with a high burden of coronary artery disease. In patients with acute coronary syndromes (ACS), CKD is highly prevalent and associated with poor short- and long-term outcomes. Management of patients with CKD presenting with ACS is more complex than in the general population because of the lack of well-designed randomized trials assessing therapeutic strategies in such patients. The almost uniform exclusion of patients with CKD from randomized studies evaluating new targeted therapies for ACS, coupled with concerns about further deterioration of renal function and therapy-related toxic effects, may explain the less frequent use of proven medical therapies in this subgroup of high-risk patients. However, these patients potentially have much to gain from conventional revascularization strategies used in the general population. The objective of this review is to summarize the current evidence regarding the epidemiology and the clinical and prognostic relevance of CKD in ACS patients, in particular with respect to unresolved issues and uncertainties regarding recommended medical therapies and coronary revascularization strategies.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

